Company intelligence
Alliance for Regenerative Medicine
We champion the benefits of engineered cell therapies & genetic medicines for patients, healthcare systems & society.
About Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society. As a community, ARM builds the future of medicine by convening the sector, facilitating influential exchanges on policies and practices, and advancing the narrative with data and analysis. We actively engage key stakeholders to enable the development of advanced therapies and modernize healthcare systems so that patients benefit from durable, potentially curative treatments. As the global voice of the sector, we represent more than 400 members across 25 countries, including emerging and established biotechnology companies, academic and medical research institutions, and patient organizations. To learn more about ARM or to become a member, visit http://www.alliancerm.org.
Verified activity
Signals from Alliance for Regenerative Medicine
8 published signals
Research & Knowledge
Alliance for Regenerative Medicine published a new story on In Vivo reviewing the recent release of Janus 2.0, ARM's multi-year strategic plan.
Reported by Alliance for Regenerative Medicine
Presence & Recognition
Alliance for Regenerative Medicine is hosting the Colorado cohort for Life Science Cares, Inc. Climb4Community event in Denver next Monday.
Reported by Richard Wilson
Presence & Recognition
Alliance for Regenerative Medicine is attending the Cell & Gene Meeting on the Mesa in Phoenix on October 5-7, 2026.
Reported by Alliance for Regenerative Medicine
Legal & Regulatory
Alliance for Regenerative Medicine's Tennessee Oncology program achieved FACT Community IEC Accreditation, marking it as the first community-based oncology program to do so.
Reported by Alliance for Regenerative Medicine
Capital & Finance
Alliance for Regenerative Medicine reported seven approvals between the United States and the European Union for its near-term cell and gene therapy pipeline in 2026.
Reported by Alliance for Regenerative Medicine
Capital & Finance
Alliance for Regenerative Medicine noted that the U.S. pipeline has 10+ products potentially nearing a regulatory submission in the coming months.
Reported by Alliance for Regenerative Medicine
Presence & Recognition
Alliance for Regenerative Medicine is hosting a live webinar for first-time and returning attendees at the Cell & Gene Meeting on the Mesa on Friday, September 4th at 11:00 AM ET.
Reported by Alliance for Regenerative Medicine
People
Alliance for Regenerative Medicine welcomed Suzy Draddy Jacobs as its next Chief Operating Officer.
Reported by Alliance for Regenerative Medicine